ArticlePloS one2025
VISION: View-specific integrated segmentation-classification framework for accurate brain tumor detection in MRI scans.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brain tumors are an increasing global health concern, and accurate diagnosis is essential for improving patient outcomes. Although existing Magnetic Resonance Imaging (MRI)-based machine learning utilizes computer vision for tumor diagnosis, these methods are limited. They either focus solely on segmentation, which does not facilitate tumor detection, or on classification, which fails to identify tumor boundaries. To overcome these limitations, we propose the "View-specific Integrated Segmentation-Classification" (VISION) framework, designed for more accurate brain tumor diagnosis by integrating both segmentation and classification processes. The VISION framework introduces two novel components: (1) a View Classifier that determines MRI orientation (axial, coronal, or sagittal), and (2) a view-specific integrated network combining a customized segmentation model with a classification header. This architecture simultaneously identifies tumor boundaries (segmentation) and detects tumor presence (classification). We evaluated our approach using publicly available data and compared it against state-of-the-art MRI-based tumor diagnosis techniques. The VISION framework outperformed existing methods, achieving a Dice score of 0.89, an IoU of 0.87, and an F1 score of 0.98 while maintaining competitive computational efficiency. The proposed VISION framework offers a robust solution for brain tumor diagnosis by integrating view classification, segmentation, and detection into a unified system. Its high accuracy and efficiency demonstrate significant potential for clinical applications in improving tumor diagnosis and treatment planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.